


Antios Therapeutics
Biotechnology Research • Atlanta, Georgia, United States • 1-10 Employees
Company overview
| Headquarters | Atlanta, Georgia, United States |
| Phone number | +12156969659 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
Key Contact at Antios Therapeutics
Mark Lockwood
Director, Process Research and Manufacturing
About Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.
Antios Therapeutics revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $1,500,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | $75,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Antios Therapeutics Tech Stack
Discover the technologies and tools that power Antios Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
JavaScript libraries
Tag managers
Hosting
JavaScript libraries
Miscellaneous
JavaScript libraries
Miscellaneous
Font scripts
JavaScript libraries
Frequently asked questions
4.8
40,000 users



